Low-Dose Aspirin Use Does Not Increase Survival in 2 Independent Population-Based Cohorts of Patients With Esophageal or Gastric Cancer

Gastroenterology- United Kingdom

doi 10.1053/j.gastro.2017.10.044

Full Text

Abstract

Available in

Date

Authors

Publisher

Elsevier BV

Related search

Continued Use of Low-Dose Aspirin Does Not Increase the Risk of Bleeding During or After Endoscopic Submucosal Dissection for Early Gastric Cancer

Gastric Cancer
Cancer ResearchMedicineOncologyGastroenterology
2013English

Low-Dose Aspirin Use and Survival in Colorectal Cancer: Results From a Population-Based Cohort Study

BMC Cancer
Cancer ResearchOncologyGenetics
2018English

Low-Dose Aspirin Use and Cancer Characteristics: A Population-Based Cohort Study

British Journal of Cancer
Cancer ResearchOncology
2013English

Low-Dose Aspirin Use and Survival in Breast Cancer Patients: A Nationwide Cohort Study

Cancer Epidemiology
Cancer ResearchEpidemiologyOncology
2017English

Low-Dose Aspirin Use and Survival in Breast Cancer Patients: A Nationwide Cohort Study

Cancer Epidemiology
Cancer ResearchEpidemiologyOncology
2017English

Glycemic Control and Survival of Patients With Coexisting Diabetes Mellitus and Gastric or Esophageal Cancer

Future Science OA
MedicineBiotechnology
2019English

Statin Use After Diagnosis Is Associated With an Increased Survival in Esophageal Cancer Patients: A Belgian Population-Based Study

Cancer Causes and Control
Cancer ResearchOncology
2019English

Overexpression of Transmembrane Protein BST2 Is Associated With Poor Survival of Patients With Esophageal, Gastric, or Colorectal Cancer

Annals of Surgical Oncology
OncologySurgery
2016English

Statin Use After Esophageal Cancer Diagnosis and Survival: A Population Based Cohort Study

Cancer Epidemiology
Cancer ResearchEpidemiologyOncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy